Cure Delivery Technologies Private Limited - Due diligence report

A 360° intelligence report on Cure Delivery Technologies Private Limited: trust score, financial health, credit view, compliance, directors,…

2020-06-15 Cochin, Kerala Active Unlisted
Share
CD Cure Delivery Technologies Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Cure Delivery Technologies Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
72/100
Trust Score
Moderate

Cure Delivery Technologies Private Limited is assessed as Moderate with a Trust Score of 72/100. Cure Delivery Technologies Private Limited is an active private limited indian non-government company incorporated in 2020, operating in the Pharma sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Cure Delivery Technologies Private Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
72/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
75/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
40/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 1 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Elevated gearing (D/E 38%).
  • Working-capital cover adequate.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 75/100 Low Risk
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2022 - filings overdue.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
SARATH SANKAR 01234567 Director 01/04/2018 6 yrs Approved
AMRITHA RAMADAS 01234567 Director 01/04/2018 6 yrs Approved
FAIZAL VERUNKUNDAM 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2021 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
14 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 80
Growth signals & trust indicators
Operating for 6 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Statutory filings appear overdue.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence76/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment49/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view32/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
31 Mar 2023
Last AGM held
Annual general meeting
31 Mar 2022
Latest balance sheet
Filed with ROC
08 Feb 2022
Securities allotted
130 Equity Shares Without Differential Rights - 14.95 Lakh raised
04 Jan 2022
Securities allotted
113 Equity Shares Without Differential Rights - 13.00 Lakh raised
20 Dec 2021
Securities allotted
200 Equity Shares Without Differential Rights - 23.00 Lakh raised
12 Nov 2021
Securities allotted
226 Equity Shares Without Differential Rights - 25.99 Lakh raised
06 Oct 2021
Securities allotted
130 Equity Shares Without Differential Rights - 14.95 Lakh raised
16 Jul 2021
Securities allotted
407 Equity Shares Without Differential Rights - 46.81 Lakh raised
08 Jun 2021
Securities allotted
87 Equity Shares Without Differential Rights - 10.01 Lakh raised
18 May 2021
Securities allotted
87 Equity Shares Without Differential Rights - 10.01 Lakh raised
20 Apr 2021
Securities allotted
108 Equity Shares Without Differential Rights - 12.42 Lakh raised
22 Mar 2021
Securities allotted
174 Equity Shares Without Differential Rights - 20.01 Lakh raised
25 Jan 2021
Securities allotted
155 Equity Shares Without Differential Rights - 17.83 Lakh raised
09 Dec 2020
Securities allotted
183 Equity Shares Without Differential Rights - 21.05 Lakh raised
21 Nov 2020
Securities allotted
65 Equity Shares Without Differential Rights - 7.48 Lakh raised
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2021 annual return.
Capital has been raised through 14 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Worldcom Solutions Limited U45201MH2005PLC274034 Malad West, Maharashtra, India
Royal India Gems And Jewels Private Limited U51398TN2004PTC052527 Chennai-600 101, Tamil Nadu, India
Venable Management Services Private Limited U74140KA2010PTC054876 Bangalore, Karnataka, India
Lazycocktails Beverages Private Limited U15549DL2020PTC367653 Delhi, Delhi, India
Fresh Joy Agro Private Limited U01119MH2020PTC352429 Mumbai, Maharashtra, India
Modi Cube Labs Ai Limited L51909DL1985PLC022270 New Delhi, Delhi, India
Intercontinental Proex Private Limited U52100KA2012PTC065413 Bangalore, Karnataka, India
Bishwanath Vinimay Private Limited U51909WB2004PTC100063 Kolkata, West Bengal, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Cure Delivery Technologies Private Limited before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Cure Delivery Technologies Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Cure Delivery Technologies Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 72/100, distress signals and MSME payment-delay disclosures - know whether Cure Delivery Technologies Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Cure Delivery Technologies Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Cure Delivery Technologies Private Limited an active company?

Cure Delivery Technologies Private Limited has MCA status “Active” with a compliance score of 75/100 (Low Risk).

Is Cure Delivery Technologies Private Limited financially healthy?

Cure Delivery Technologies Private Limited has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Cure Delivery Technologies Private Limited?

Its overall Trust Score is 72/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Cure Delivery Technologies Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Cure Delivery Technologies Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Cure Delivery Technologies Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2022 - filings overdue. Overall compliance score: 75/100 (Low Risk).

Is it risky to lend to Cure Delivery Technologies Private Limited?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.